1. Executive Summary
1.1. Global Bio Active Protein and Peptides Market Snapshot
1.2. Future Projections
1.3. Key Market Trends
1.4. Regional Snapshot, by Value, 2024
1.5. Analyst Recommendations
2. Market Overview
2.1. Market Definitions and Segmentations
2.2. Market Dynamics
2.2.1. Drivers
2.2.2. Restraints
2.2.3. Market Opportunities
2.3. Value Chain Analysis
2.4. Porter’s Five Forces Analysis
2.5. COVID-19 Impact Analysis
2.5.1. Supply
2.5.2. Demand
2.6. Impact of Ukraine-Russia Conflict
2.7. Economic Overview
2.7.1. World Economic Projections
2.8. PESTLE Analysis
3. Global Bio Active Protein and Peptides Market Outlook, 2018 - 2031
3.1. Global Bio Active Protein and Peptides Market Outlook, by Source, Value (US$ Bn), 2018 - 2031
3.1.1. Key Highlights
3.1.1.1. Plant
3.1.1.2. Animal
3.1.1.3. Marine
3.2. Global Bio Active Protein and Peptides Market Outlook, by Application, Value (US$ Bn), 2018 - 2031
3.2.1. Key Highlights
3.2.1.1. Functional Food
3.2.1.2. Functional Beverages
3.2.1.3. Dietary Supplements
3.2.1.4. Animal Nutrition
3.2.1.5. Personal Care
3.2.1.6. Others (Printing & Painting)
3.3. Global Bio Active Protein and Peptides Market Outlook, by Region, Value (US$ Bn), 2018 - 2031
3.3.1. Key Highlights
3.3.1.1. North America
3.3.1.2. Europe
3.3.1.3. Asia Pacific
3.3.1.4. Latin America
3.3.1.5. Middle East & Africa
4. North America Bio Active Protein and Peptides Market Outlook, 2018 - 2031
4.1. North America Bio Active Protein and Peptides Market Outlook, by Source, Value (US$ Bn), 2018 - 2031
4.1.1. Key Highlights
4.1.1.1. Plant
4.1.1.2. Animal
4.1.1.3. Marine
4.2. North America Bio Active Protein and Peptides Market Outlook, by Application, Value (US$ Bn), 2018 - 2031
4.2.1. Key Highlights
4.2.1.1. Functional Food
4.2.1.2. Functional Beverages
4.2.1.3. Dietary Supplements
4.2.1.4. Animal Nutrition
4.2.1.5. Personal Care
4.2.1.6. Others (Printing & Painting)
4.2.2. BPS Analysis/Market Attractiveness Analysis
4.3. North America Bio Active Protein and Peptides Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
4.3.1. Key Highlights
4.3.1.1. U.S. Bio Active Protein and Peptides Market by Source, Value (US$ Bn), 2018 - 2031
4.3.1.2. U.S. Bio Active Protein and Peptides Market by Application, Value (US$ Bn), 2018 - 2031
4.3.1.3. Canada Bio Active Protein and Peptides Market by Source, Value (US$ Bn), 2018 - 2031
4.3.1.4. Canada Bio Active Protein and Peptides Market by Application, Value (US$ Bn), 2018 - 2031
4.3.2. BPS Analysis/Market Attractiveness Analysis
5. Europe Bio Active Protein and Peptides Market Outlook, 2018 - 2031
5.1. Europe Bio Active Protein and Peptides Market Outlook, by Source, Value (US$ Bn), 2018 - 2031
5.1.1. Key Highlights
5.1.1.1. Plant
5.1.1.2. Animal
5.1.1.3. Marine
5.2. Europe Bio Active Protein and Peptides Market Outlook, by Application, Value (US$ Bn), 2018 - 2031
5.2.1. Key Highlights
5.2.1.1. Functional Food
5.2.1.2. Functional Beverages
5.2.1.3. Dietary Supplements
5.2.1.4. Animal Nutrition
5.2.1.5. Personal Care
5.2.1.6. Others (Printing & Painting)
5.2.2. BPS Analysis/Market Attractiveness Analysis
5.3. Europe Bio Active Protein and Peptides Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
5.3.1. Key Highlights
5.3.1.1. Germany Bio Active Protein and Peptides Market by Source, Value (US$ Bn), 2018 - 2031
5.3.1.2. Germany Bio Active Protein and Peptides Market by Application, Value (US$ Bn), 2018 - 2031
5.3.1.3. U.K. Bio Active Protein and Peptides Market by Source, Value (US$ Bn), 2018 - 2031
5.3.1.4. U.K. Bio Active Protein and Peptides Market by Application, Value (US$ Bn), 2018 - 2031
5.3.1.5. France Bio Active Protein and Peptides Market by Source, Value (US$ Bn), 2018 - 2031
5.3.1.6. France Bio Active Protein and Peptides Market by Application, Value (US$ Bn), 2018 - 2031
5.3.1.7. Italy Bio Active Protein and Peptides Market by Source, Value (US$ Bn), 2018 - 2031
5.3.1.8. Italy Bio Active Protein and Peptides Market by Application, Value (US$ Bn), 2018 - 2031
5.3.1.9. Turkey Bio Active Protein and Peptides Market by Source, Value (US$ Bn), 2018 - 2031
5.3.1.10. Turkey Bio Active Protein and Peptides Market by Application, Value (US$ Bn), 2018 - 2031
5.3.1.11. Russia Bio Active Protein and Peptides Market by Source, Value (US$ Bn), 2018 - 2031
5.3.1.12. Russia Bio Active Protein and Peptides Market by Application, Value (US$ Bn), 2018 - 2031
5.3.1.13. Rest of Europe Bio Active Protein and Peptides Market by Source, Value (US$ Bn), 2018 - 2031
5.3.1.14. Rest of Europe Bio Active Protein and Peptides Market by Application, Value (US$ Bn), 2018 - 2031
5.3.2. BPS Analysis/Market Attractiveness Analysis
6. Asia Pacific Bio Active Protein and Peptides Market Outlook, 2018 - 2031
6.1. Asia Pacific Bio Active Protein and Peptides Market Outlook, by Source, Value (US$ Bn), 2018 - 2031
6.1.1. Key Highlights
6.1.1.1. Plant
6.1.1.2. Animal
6.1.1.3. Marine
6.2. Asia Pacific Bio Active Protein and Peptides Market Outlook, by Application, Value (US$ Bn), 2018 - 2031
6.2.1. Key Highlights
6.2.1.1. Functional Food
6.2.1.2. Functional Beverages
6.2.1.3. Dietary Supplements
6.2.1.4. Animal Nutrition
6.2.1.5. Personal Care
6.2.1.6. Others (Printing & Painting)
6.2.2. BPS Analysis/Market Attractiveness Analysis
6.3. Asia Pacific Bio Active Protein and Peptides Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
6.3.1. Key Highlights
6.3.1.1. China Bio Active Protein and Peptides Market by Source, Value (US$ Bn), 2018 - 2031
6.3.1.2. China Bio Active Protein and Peptides Market by Application, Value (US$ Bn), 2018 - 2031
6.3.1.3. Japan Bio Active Protein and Peptides Market by Source, Value (US$ Bn), 2018 - 2031
6.3.1.4. Japan Bio Active Protein and Peptides Market by Application, Value (US$ Bn), 2018 - 2031
6.3.1.5. South Korea Bio Active Protein and Peptides Market by Source, Value (US$ Bn), 2018 - 2031
6.3.1.6. South Korea Bio Active Protein and Peptides Market by Application, Value (US$ Bn), 2018 - 2031
6.3.1.7. India Bio Active Protein and Peptides Market by Source, Value (US$ Bn), 2018 - 2031
6.3.1.8. India Bio Active Protein and Peptides Market by Application, Value (US$ Bn), 2018 - 2031
6.3.1.9. Southeast Asia Bio Active Protein and Peptides Market by Source, Value (US$ Bn), 2018 - 2031
6.3.1.10. Southeast Asia Bio Active Protein and Peptides Market by Application, Value (US$ Bn), 2018 - 2031
6.3.1.11. Rest of Asia Pacific Bio Active Protein and Peptides Market by Source, Value (US$ Bn), 2018 - 2031
6.3.1.12. Rest of Asia Pacific Bio Active Protein and Peptides Market by Application, Value (US$ Bn), 2018 - 2031
6.3.2. BPS Analysis/Market Attractiveness Analysis
7. Latin America Bio Active Protein and Peptides Market Outlook, 2018 - 2031
7.1. Latin America Bio Active Protein and Peptides Market Outlook, by Source, Value (US$ Bn), 2018 - 2031
7.1.1. Key Highlights
7.1.1.1. Plant
7.1.1.2. Animal
7.1.1.3. Marine
7.2. Latin America Bio Active Protein and Peptides Market Outlook, by Application, Value (US$ Bn), 2018 - 2031
7.2.1. Key Highlights
7.2.1.1. Functional Food
7.2.1.2. Functional Beverages
7.2.1.3. Dietary Supplements
7.2.1.4. Animal Nutrition
7.2.1.5. Personal Care
7.2.1.6. Others (Printing & Painting)
7.2.2. BPS Analysis/Market Attractiveness Analysis
7.3. Latin America Bio Active Protein and Peptides Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
7.3.1. Key Highlights
7.3.1.1. Brazil Bio Active Protein and Peptides Market by Source, Value (US$ Bn), 2018 - 2031
7.3.1.2. Brazil Bio Active Protein and Peptides Market by Application, Value (US$ Bn), 2018 - 2031
7.3.1.3. Mexico Bio Active Protein and Peptides Market by Source, Value (US$ Bn), 2018 - 2031
7.3.1.4. Mexico Bio Active Protein and Peptides Market by Application, Value (US$ Bn), 2018 - 2031
7.3.1.5. Argentina Bio Active Protein and Peptides Market by Source, Value (US$ Bn), 2018 - 2031
7.3.1.6. Argentina Bio Active Protein and Peptides Market by Application, Value (US$ Bn), 2018 - 2031
7.3.1.7. Rest of Latin America Bio Active Protein and Peptides Market by Source, Value (US$ Bn), 2018 - 2031
7.3.1.8. Rest of Latin America Bio Active Protein and Peptides Market by Application, Value (US$ Bn), 2018 - 2031
7.3.2. BPS Analysis/Market Attractiveness Analysis
8. Middle East & Africa Bio Active Protein and Peptides Market Outlook, 2018 - 2031
8.1. Middle East & Africa Bio Active Protein and Peptides Market Outlook, by Source, Value (US$ Bn), 2018 - 2031
8.1.1. Key Highlights
8.1.1.1. Plant
8.1.1.2. Animal
8.1.1.3. Marine
8.2. Middle East & Africa Bio Active Protein and Peptides Market Outlook, by Application, Value (US$ Bn), 2018 - 2031
8.2.1. Key Highlights
8.2.1.1. Functional Food
8.2.1.2. Functional Beverages
8.2.1.3. Dietary Supplements
8.2.1.4. Animal Nutrition
8.2.1.5. Personal Care
8.2.1.6. Others (Printing & Painting)
8.2.2. BPS Analysis/Market Attractiveness Analysis
8.3. Middle East & Africa Bio Active Protein and Peptides Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
8.3.1. Key Highlights
8.3.1.1. GCC Bio Active Protein and Peptides Market by Source, Value (US$ Bn), 2018 - 2031
8.3.1.2. GCC Bio Active Protein and Peptides Market by Application, Value (US$ Bn), 2018 - 2031
8.3.1.3. South Africa Bio Active Protein and Peptides Market by Source, Value (US$ Bn), 2018 - 2031
8.3.1.4. South Africa Bio Active Protein and Peptides Market by Application, Value (US$ Bn), 2018 - 2031
8.3.1.5. Egypt Bio Active Protein and Peptides Market by Source, Value (US$ Bn), 2018 - 2031
8.3.1.6. Egypt Bio Active Protein and Peptides Market by Application, Value (US$ Bn), 2018 - 2031
8.3.1.7. Nigeria Bio Active Protein and Peptides Market by Source, Value (US$ Bn), 2018 - 2031
8.3.1.8. Nigeria Bio Active Protein and Peptides Market by Application, Value (US$ Bn), 2018 - 2031
8.3.1.9. Rest of Middle East & Africa Bio Active Protein and Peptides Market by Source, Value (US$ Bn), 2018 - 2031
8.3.1.10. Rest of Middle East & Africa Bio Active Protein and Peptides Market by Application, Value (US$ Bn), 2018 - 2031
8.3.2. BPS Analysis/Market Attractiveness Analysis
9. Competitive Landscape
9.1. Company Market Share Analysis, 2024
9.2. Competitive Dashboard
9.3. Company Profiles
9.3.1. BASF SE
9.3.1.1. Company Overview
9.3.1.2. Therapy Portfolio
9.3.1.3. Financial Overview
9.3.1.4. Business Strategies and Development
9.3.2. Seagarden AS
9.3.2.1. Company Overview
9.3.2.2. Therapy Portfolio
9.3.2.3. Financial Overview
9.3.2.4. Business Strategies and Development
9.3.3. ADM
9.3.3.1. Company Overview
9.3.3.2. Therapy Portfolio
9.3.3.3. Financial Overview
9.3.3.4. Business Strategies and Development
9.3.4. Ingredia SA
9.3.4.1. Company Overview
9.3.4.2. Therapy Portfolio
9.3.4.3. Financial Overview
9.3.4.4. Business Strategies and Development
9.3.5. Rousselot S.A.S.
9.3.5.1. Company Overview
9.3.5.2. Therapy Portfolio
9.3.5.3. Financial Overview
9.3.5.4. Business Strategies and Development
9.3.6. Peptan
9.3.6.1. Company Overview
9.3.6.2. Therapy Portfolio
9.3.6.3. Financial Overview
9.3.6.4. Business Strategies and Development
9.3.7. Kerry Group plc
9.3.7.1. Company Overview
9.3.7.2. Therapy Portfolio
9.3.7.3. Financial Overview
9.3.7.4. Business Strategies and Development
9.3.8. CP Kelco
9.3.8.1. Company Overview
9.3.8.2. Therapy Portfolio
9.3.8.3. Financial Overview
9.3.8.4. Business Strategies and Development
9.3.9. Omega Protein Corporation
9.3.9.1. Company Overview
9.3.9.2. Therapy Portfolio
9.3.9.3. Financial Overview
9.3.9.4. Business Strategies and Development
9.3.10. E.I. Du Pont De Nemours
9.3.10.1. Company Overview
9.3.10.2. Therapy Portfolio
9.3.10.3. Financial Overview
9.3.10.4. Business Strategies and Development
10. Appendix
10.1. Research Methodology
10.2. Report Assumptions
10.3. Acronyms and Abbreviations